December 30, 2024

Nutrafol Safety Signal Emerges in Case Study

A previously healthy 26-year-old developed severe liver injury after using Nutrafol, with a biopsy confirming marked necroinflammatory damage with complete resolution upon discontinuation.

Conexiant

December 30, 2024

Nine Early Signs Precede Youth MS Diagnosis

Researchers identified a set of symptoms that could be used to predict children who will be diagnosed with multiple sclerosis.

Conexiant

December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant

December 27, 2024

More Aerobic Minutes Equals More Weight Loss

At 150 minutes per week, participants averaged a weight loss of 2.79 kg, while at 300 minutes per week, weight loss increased to 4.19 kg.

Conexiant

December 24, 2024

Merck to Halt Zinplava by January

Merck discontinuing Zinplava, an antibody drug designed to prevent the recurrence of a bacterial infection that can lead to fatal diarrhea, as disclosed on the FDA's website.

Reuters

December 23, 2024

FDA Grants Accelerated Approval to Encorafenib Combination for BRAF V600E–Mutant Metastatic Colorectal Cancer

On December 20, 2024, the U.S. Food and Drug Administration granted accelerated approval to encorafenib (Braftovi) in combination with cetuximab and modified fluorouracil, leucovorin, and oxaliplatin ...

The ASCO Post

December 23, 2024

Long-Term Overall Survival With Adjuvant Gemcitabine/Capecitabine vs Gemcitabine in Pancreatic Adenocarcinoma

In a long-term analysis of the phase III ESPAC4 trial, reported in the Journal of Clinical Oncology, Palmer et al found adjuvant gemcitabine/capecitabine was associated with prolonged overall survival...

The ASCO Post

December 23, 2024

Colonoscopy Prep: 48 Risk Factors Found

Study of 358,257 patients reveals Medicaid insurance and psychiatric disease predict poor colonoscopy preparation more strongly than traditionally assumed factors such as age or timing.

Conexiant

December 23, 2024

Trump Team Targets Immediate WHO Exit, Experts Say

"I have it on good authority that he plans to withdraw, probably on Day One or very early in his administration."

Reuters